磁化率能够衡量磁珠向磁力架迁移的速度,其大小取决于铁含量和氧化铁的特性。Dynabeads磁珠的磁化率是指质量磁化率,单位可以是cgs单位/g或m^3/kg(国际单位制)。对于亚铁磁性和铁磁性物质,质量磁化率取决于磁场强度(H),这些物质的磁化强度与H不是线性关系,而是随着场强增加而趋于饱和。因此, Dynabeads磁珠的质量磁化率是在固定条件下由标准操作程序而测定的。我们产品目录中给出的质量磁化率是国际单位制。磁化率由从高斯(cgs、emu)单位向国际单位的转换,是通过“高斯系数(emu/g或cgs/g)x 4π x 10^-3”而实现的。所得单位也被称为合理化质量磁化率,与(国际单位制)无量纲磁化率单位有所区别。通常,质量磁化率可用来衡量在非均匀磁场中影响物体的力(Fz)。测定Dynabeads磁珠的质量磁化率时,首先对样本称重,然后将样本放置于已知强度的磁场中。随后,再次称重得到样本重量(F1),并与关闭磁场时样本的重量(F0)进行对比。使用下述公式计算磁化率:K x 10^–3 = [(F1-F0) x m x 0.335 x 10^6],K表示质量为m的样本的质量磁化率。最后,将磁化率转换为国际单位制。
Development and mechanism of ?-secretase modulators for Alzheimer's disease.
Authors:Crump CJ, Johnson DS, Li YM
Journal:Biochemistry
PubMed ID:23614767
'?-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains. ?-Secretase cleaves the amyloid precursor proteins (APP) to release Aß peptides that likely play a causative role in the pathogenesis of Alzheimer's disease (AD). In addition, ?-secretase cleaves Notch and other type I ... More
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Authors:Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P
Journal:
PubMed ID:26136856
'Synaptic dysfunction and degeneration are central events in Alzheimer''s disease (AD) pathophysiology that are thought to occur early in disease progression. Synaptic pathology may be studied by examining protein biomarkers specific for different synaptic elements. We recently showed that the dendritic protein neurogranin (Ng), including the endogenous Ng peptide 48 ... More
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Authors:Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H
Journal:
PubMed ID:25591542
'Senile plaques in Alzheimer''s disease (AD) are composed of amyloid-ß (Aß), especially N-truncated forms including Aß4-42. These are thought to be neurotoxic. However, individuals may live for decades with biomarker evidence of cerebral ß-amyloidosis (positive amyloid PET imaging and/or low cerebrospinal fluid levels of the 42 amino acid form of ... More
Pyroglutamate amyloid ß (Aß) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease.
Authors:Wittnam JL, Portelius E, Zetterberg H, Gustavsson MK, Schilling S, Koch B, Demuth HU, Blennow K, Wirths O, Bayer TA
Journal:J Biol Chem
PubMed ID:22267726
'Pyroglutamate-modified Aß peptides at amino acid position three (Aß(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). Aß(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim of the present work was to study the ... More
APP metabolism regulates tau proteostasis in human cerebral cortex neurons.
Authors:Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, Saurat N, McGlade A, Kirwan P, Blennow K, Hardy J, Zetterberg H, Livesey FJ
Journal:
PubMed ID:25921538
'Accumulation of Aß peptide fragments of the APP protein and neurofibrillary tangles of the microtubule-associated protein tau are the cellular hallmarks of Alzheimer''s disease (AD). To investigate the relationship between APP metabolism and tau protein levels and phosphorylation, we studied human-stem-cell-derived forebrain neurons with genetic forms of AD, all of ... More